Top Story

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014

BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of Medicine in New Orleans, outlines recent trial data and FDA updates related to CV and diabetes care.

During a session, Ferdinand discussed a trial that assessed the impact of the GLP-1 agonist dulaglutide on BP and heart rate in a cohort of 755 patients. Ferdinand, who was the principal investigator for the trial, noted a small increase in heart rate with dulaglutide 1.5 mg compared with placebo, but similar results between placebo and dulaglutide 0.75 mg. Patients who received the 1.5 mg dose also exhibited a significant decrease in BP during a 24-hour period. He noted that, while the trial did not assess CV outcomes, results suggest that GLP-1 agonists may aid in BP control, although long-term outcome trials should be performed to determine whether the observed heart rate increase is potentially problematic.

In the Journals

Reduced lung function in infancy linked to asthma at age 8

October 30, 2014
A cohort of Finnish children who had reduced lung function in infancy were more likely to have had physician-diagnosed asthma or currently have asthma during follow-up…
figure In the Journals

Adult eczema associated with increased risk of injury

October 30, 2014
Researchers found a correlation between adult eczema and an increased risk of injury, particularly fracture and bone or joint injury.Using the 2012 National Health…
In the Journals

Better diet quality benefits vision, study finds

October 30, 2014
Adherence to dietary guidelines was associated with a lowered long-term risk of visual impairments in a study recently published in the American Journal of
More News Headlines »

Nicox finalizes acquisition of Aciex Therapeutics

October 30, 2014
Nicox has announced the completion of its acquisition of Aciex Therapeutics, according to a press release.In July,
More »
Blog

When considering new technology, think about the three stakeholders

October 22, 2014
At this latest AAO meeting, we saw a variety of new devices and drugs to excite us, challenge our current treatment…
More »
Meeting News Coverage Video
figure

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014
BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at…
More »